Babol University of Medical Sciences Caspian Journal of Surgery 3115-9087 1 1 2025 03 01 Editorial: Welcome to the First Issue of Caspian Journal of Surgery 728391 EN Pouya Tayebi Associate Professor of Vascular and Endovascular Surgery, Department of Vascular and Endovascular Surgery, Rouhani Hospital, Faculty of Medicine, Babol University of Medical Sciences, Babol, Iran. 0000-0002-6923-0221 Journal Article 2025 08 15 Welcome to the inaugural issue of the Caspian Journal of Surgery (CJS), the official scientific journal of Babol University of Medical Sciences. As we embark on this exciting journey, it is with great pride that we introduce CJS as a peer-reviewed, open-access platform committed to advancing surgical knowledge and fostering academic exchange on both national and international levels. In the rapidly evolving field of surgery, it is crucial to maintain a dynamic and responsive platform for the dissemination of high-quality scientific research. The Caspian Journal of Surgery aims to fill this gap by providing a reputable and accessible space for researchers, surgeons, educators, and healthcare professionals to share their innovative work. Whether through original research articles, clinical trials, systematic reviews, case reports, or studies related to surgical education and innovation, CJS seeks to promote collaboration and inspire new ideas in the surgical sciences. We are deeply committed to ensuring that the work we publish exemplifies methodological rigor, scientific originality, clinical relevance, and ethical integrity. Each submission undergoes a rigorous double-blind peer review process, managed by our distinguished editorial board, consisting of academics and clinical experts from renowned institutions around the world. This process not only ensures the quality of the work but also upholds the confidentiality and impartiality essential for scholarly exchange. At CJS, we strongly believe that open access to scientific knowledge is a cornerstone of academic growth and improved patient care. All articles accepted for publication are freely available to readers worldwide, ensuring that the latest advancements in surgical research and practice are accessible without barriers. This commitment to open access reflects our mission to contribute meaningfully to the global community of surgeons and healthcare professionals. As we move forward, we warmly invite researchers, postgraduate students, faculty members, and practicing surgeons to contribute to the continued growth of CJS. Whether through manuscript submissions, critical commentary, or participation in the peer review process, your involvement will help strengthen the global voice of surgical science and support the future of patient care. Together, we can work to enhance surgical practices and outcomes for patients around the world. We are excited to have you join us in this journey of innovation, collaboration, and excellence in surgery. Call for Submissions: We are currently welcoming submissions to the Caspian Journal of Surgery. If you have research, case studies, or reviews that you believe would contribute to the global discussion on surgery, we encourage you to submit your work to CJS. Your contributions will not only add to the growing body of surgical knowledge but also play an integral role in shaping the future of patient care. Thank you for being part of this exciting new chapter in the world of surgical science. We look forward to your valuable contributions. Pouya Tayebi Editor-in-Chief Caspian Journal of Surgery https://www.caspjs.com/article_728391_35d98551a246a7090ec05cce4eae4ae0.pdf

Babol University of Medical Sciences Caspian Journal of Surgery 3115-9087 1 1 2025 03 01 Bilateral and Simultaneous Quadriceps Tendon Rupture in a Chronic Kidney Disease Patient: A Rare and Severe Presentation 1 6 725376 10.22088/caspjs.2025.725376 EN Majid Khalilizad Department of Orthopedic and Trauma Surgery, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran. 0000-0002-5711-0492 Amir Mahmoud Afshar Clinical Research Development Unit, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran. 0000-0003-2826-1571 Mobin Marzban Abbas Abadi Clinical Research Development Unit, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran. 0009-0001-0845-7924 Journal Article 2025 06 21 Background: Bilateral quadriceps tendon rupture is a rare and severe injury that is often associated with chronic conditions such as chronic renal failure, hyperparathyroidism, and long-term hemodialysis. This case report presents a rare instance of bilateral quadriceps tendon rupture in a patient with chronic renal failure, highlighting the underlying pathophysiological mechanisms and diagnostic challenges. Case Presentation: A 37-year-old man with a seven-year history of chronic kidney disease, treated with hemodialysis, presented with bilateral knee pain, swelling, and an inability to walk after falling on a flat surface. Clinical examination revealed an inability to actively extend both knees, with palpable suprapatellar gaps. Imaging studies, including X-ray and MRI, confirmed bilateral quadriceps tendon rupture. Laboratory tests revealed elevated parathyroid hormone (PTH) levels, supporting the diagnosis of secondary hyperparathy-roidism due to chronic renal failure. Treatment and Outcome: The patient underwent surgical repair using the Krackow method with anchor sutures. Postoperative rehabilitation included physiotherapy, and four months after surgery, the patient regained full knee extension and 100° of flexion. He was able to return to normal activities without complications. Discussion: Bilateral quadriceps tendon rupture is rarely seen in individuals with chronic kidney disease, with secondary hyperparathyroidism being a key contributor. The weakened tendons, combined with the trauma, can result in tendon rupture even with minimal injury. Early diagnosis through imaging, particularly MRI, is crucial in such cases. This case underscores the importance of recognizing the risks of tendon rupture in high-risk populations and implementing preventive measures. Conclusion: Hyperparathyroidism secondary to chronic renal failure likely contributes to the weakening and rupture of tendons. Timely diagnosis and surgical intervention can lead to successful outcomes in these high-risk patients.

https://www.caspjs.com/article_725376_244287dcc6874cf42f8bcb712989b2a8.pdf

Babol University of Medical Sciences Caspian Journal of Surgery 3115-9087 1 1 2025 03 01 A rare case of Zinner syndrome and grade 3 varicocele 7 10 724983 10.22088/caspjs.2025.724983 EN Hamid Shafi Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran 0000-0002-3344-923X Morteza Nasiri Student Research Committee, Babol University of Medical Sciences, Babol, Iran 0000-0003-1416-5431 Ali Akbarzadeh Pasha Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran 0000-0002-2271-3154 Niusha Jamshidi Student Research Committee, Babol University of Medical Sciences, Babol, Iran 0009-0001-8621-2252 Ali Asghar Rezaei Student Research Committee, Babol University of Medical Sciences, Babol, Iran 0000-0003-2727-1639 Zahra Shafi Clinical Research Development Center, Shahid Beheshti Hospital, Babol University of Medical Sciences, Babol, Iran 0000-0001-9330-0851 Journal Article 2025 05 03 Zinner syndrome is an uncommon congenital disorder characterized by a triad of unilateral renal agenesis, ejaculatory duct obstruction, and ipsilateral seminal vesicle cyst. In this case, we presented a 27-year-old patient with left scrotal discomfort and varicocele grade 3 and Zinner syndrome and oligospermia who underwent inguinal varicocelectomy and the patient improved semen analysis and symptoms.Keywords: Zinner syndrome, Seminal vesicle cyst, Renal agenesis, Oligospermia, Varicocele Zinner syndrome (ZS) is an uncommon congenital anomaly that exclusively affects males. The condition is characterized by a triad of anomalies: unilateral renal agenesis, ipsilateral seminal vesicle cyst, and ejaculatory tract atresia (1). We present a case of a 27-year-old man with scrotal discomfort and varicocele in the physical examination and oligospermia and find Zinner syndrome in ultrasonography underwent inguinal varicocelectomy. In this case, indication of varicocelectomy is scrotal discomfort in Zinner syndrome, had ejaculatory tract atresia but against to our expectation, semen fluid analysis improved. In this situation, (Zinner syndrome and varicocele) perform varicocelectomy help patient for infertility plan management.

https://www.caspjs.com/article_724983_1bed5a18011e373c3cbfbce76e0ba9a8.pdf

Babol University of Medical Sciences Caspian Journal of Surgery 3115-9087 1 1 2025 03 01 Anatomical classification of chronic venous obstruction: Implications for prognosis and treatment 11 17 725150 10.22088/caspjs.2025.725150 EN Mohammad Esmaeil Barbati Clinic of Vascular and Endovascular Surgery, RWTH Aachen University Hospital, Aachen, Germany 0000-0003-0709-8533 Majid Moini Vascular Surgery Department, Sina Hospital, Tehran, Iran 0000-0001-7509-8426 Houman Jalaie Clinic of Vascular and Endovascular Surgery, RWTH Aachen University Hospital, Aachen, Germany 0000-0002-1913-344X Journal Article 2025 05 31 Background: Chronic venous obstruction (CVO) of the iliofemoral tract is a significant cause of venous hypertension, leading to debilitating symptoms such as pain, swelling, and ulceration. Endovascular interventions, particularly venous stenting, have become the preferred treatment for CVO, but long-term stent patency remains variable, particularly in cases of extensive post-thrombotic disease. Objective: This study proposed a novel anatomical classification system for iliofemoral CVO, categorizing patients based on the extent of venous involvement, and evaluates its prognostic value in predicting stent patency. Materials and Methods: A retrospective multicenter study was conducted on 1,033 patients (1,207 limbs) who underwent venous stenting for symptomatic iliofemoral CVO between 2015 and 2019. The proposed classification system stratified CVO into five types based on anatomical involvement, ranging from non-thrombotic iliac vein lesions (Type 1) to extensive disease involving both the femoral and deep femoral veins (Type 5). Primary patency rates were analyzed using Kaplan-Meier survival curves, with multivariable Cox regression identifying independent predictors of patency loss. Results: At 12 months, primary patency rates progressively declined with increasing classification severity (Types 1: 94.9%, 2: 90.3%, 3: 80.8%, 4: 60.6%, 5: 39.4%). Classification type and total stent count were identified as independent predictors of primary patency loss (p < 0.001 and p = 0.002, respectively). Patients with extensive disease (Types 4 and 5) demonstrated significantly lower patency rates and higher complication rates, emphasizing the need for adjunctive strategies to optimize outcomes. Conclusion: The proposed classification system provides a structured approach for assessing disease severity in iliofemoral CVO, demonstrating significant prognostic value in predicting stent patency. By improving patient stratification and guiding treatment strategies, this system has the potential to enhance clinical decision-making and support future research efforts.

https://www.caspjs.com/article_725150_36616040a56165bd7d26a330edd19ab5.pdf

Babol University of Medical Sciences Caspian Journal of Surgery 3115-9087 1 1 2025 03 01 Demographic and Clinical Characteristics of Recipients of Cochlear Implant Prosthesis in Ayatollah Rouhani Hospital, Babol 18 24 724553 10.22088/caspjs.2025.724553 EN Kayvan Kiakojouri Department of Otorhinolaryngology, School of Medicine, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran. Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-3204-0448 Mohsen Monadi Department of Otorhinolaryngology, Rouhani Hospital, School of Medicine, Babol University of Medical Sciences, Babol, Iran. Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0002-5929-3042 Akram Ahmadi Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-2939-3285 Hossein-Ali Nikbakht Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0002-8556-431X Atieh Gorji Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-2939-3285 Hassan Khoramshahi Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0001-9615-0422 Mahboubeh Sheikhzadeh Department of Audiology, School of Rehabilitation, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0009-0008-9789-9281 Seyed Hossien Hamidi Department of Anesthesiology and Critical Care, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0002-7542-7936 Seyedeh Zohreh Zeyatabar Ahmadi Department of Speech Therapy, School of Rehabilitation, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-3204-0448 Mehdi Dehghan Department of Speech Therapy, School of Rehabilitation, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-4540-1759 Fereshteh Bagheri Department of Audiology, School of Rehabilitation, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-4419-4524 Sanaz Soltanpararst Department of Audiology, School of Rehabilitation, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-4540-1759 Sima Tajik Department of Audiology, School of Rehabilitation, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0002-2702-1747 Seyedeh Mahbobeh Mirtabar Student Research Committee, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-2679-5449 Tabasom Azimi Anesthesiology and Critical Care Department, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-3204-0448 Farkhondeh Baghdadi Mobility Impairment Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran Cochlear Implant Research Core, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0002-2702-1747 Journal Article 2025 05 21 Background: A cochlear implant is a device that directly activates the eighth nerve fibers using active electrodes. The purpose of this study was to investigate the demographic characteristics of people receiving cochlear implant prosthesis in the implant center of Ayatollah Rouhani Hospital in Babol city. Methods: This study was a descriptive and retrospective study. Demographic information of 119 individuals with hearing loss who received cochlear implant prosthesis was described. These characteristics included age, gender, age of receiving prosthesis, type of delivery, type of prosthesis, average age of auditory training, history of jaundice before birth, family marriage and several other variables. Results: 115 successful operations were reported. 61 females and 54 males underwent surgery. The average age of patients undergoing surgery was 113.37 months. The average age of onset hearing loss (93.21) was 31.83 months with a median (24.00-1.00) of 7, and the average age of starting to use hearing aids before surgery (98.97) was 42.92 months with a median (7.00-30.00) of 18. Also, based on the available data, the average age of starting listening training (125.32) is 56.98 months. Conclusion: This was a descriptive study on the data of patients receiving cochlear implant prosthesis. Demographic elements, including gender, jaundice, seizures, family medical history, and type of prosthesis, play a significant role in determining the candidacy for cochlear implants. It is recommended to conduct studies with statistical analysis and interventional studies in this center.

https://www.caspjs.com/article_724553_c200226a5bf53d0f1464d1cffd28c440.pdf

Babol University of Medical Sciences Caspian Journal of Surgery 3115-9087 1 1 2025 03 01 Evaluating The Amount of Hemoglobin Drop in Patients Undergoing Orthognathic Surgery 25 29 725378 10.22088/caspjs.2025.725378 EN Fatemeh Baladehei Student Research Committee, Babol University of Medical Sciences, Babol, Iran 0000-0002-2702-1747 Arezoo Javani Dental Materials Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-0368-1852 Mir Saeid Ramzani Clinical Research Development Unit of Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran 0000-0001-9330-0851 Seyed Ali Seyedmajidi Dental Materials Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0002-3841-0609 Alireza Babaee Darzi Dental Materials Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-3204-0448 Reza Sharifi Maxillofacial Surgeries Research Center, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran 0000-0003-3204-0448 Journal Article 2025 06 21 Background: Orthognathic surgeries are associated with significant blood loss. Several factors such as duration and method of the surgery, anesthesia technique, hemostasis, and surgeon skill affect the amount of blood loss during surgery. Given the importance of reducing blood loss during surgery and the importance of surgeon awareness of the patient's condition, the present study investigated the amount of hemoglobin loss in patients undergoing orthognathic surgery. Materials and Methods: In this cross-sectional study, patients over 18 years’ old who underwent Bilateral Sagittal Split Osteotomy (BSSO), Le Fort I, or both orthognathic (Bimax) surgeries were studied. The sampling method was convenience sampling. Exclusion criteria included patients with hemophilia, von Willebrand disease, and unpredictable complications during surgery (blood transfusion). The patient's hemoglobin was measured and recorded before and 24 hours after surgery. Also, the amount of blood loss in milliliters was recorded at the end of the surgery. Finally, the data were entered into SPSS 26 software, and Independent sample T-test, ANOVA and Pearson's correlation tests were used. A p<0.05 was considered statistically significant. Results: In this quasi-experimental study, 39 patients with a mean age of 27.54±5.72 years (range 18 to 40 years), 17 of whom (43.59%) were males who were examined. The mean duration of Bimax surgery was significantly longer than Le fort I (P=0.021) and BSSO (P<0.001); The decrease in hemoglobin in Bimax surgery was significantly greater than BSSO (P=0.035); the mean blood loss was also statistically different between BSSO and Bimax surgeries (P=0.041), with Bimax surgery being more significant. The difference in hematocrit (P=0.004) and hemoglobin before and after surgery (P<0.001) was significant between male and female patients (so their mean was higher in males), and the duration of surgery, the rate of hemoglobin loss and the amount of blood loss did not show a statistically significant difference (P>0.05). Conclusion: The amount of blood loss during Bimax surgery was greater than BSSO, but Le Fort I surgery was not different from the other methods. In general, increasing the surgical time increases the amount of blood loss and hemoglobin loss.

https://www.caspjs.com/article_725378_c591c54af4297957bb0ee2d9614e1183.pdf

Babol University of Medical Sciences Caspian Journal of Surgery 3115-9087 1 1 2025 03 01 Evaluation of Outcome and Surgical Treatment Results of Primary Malignant Chest Wall Tumors 30 36 725375 10.22088/caspjs.2025.725375 EN Seyed Reza Saghebi Department of General Surgery, School of Medicine, Tracheal Disease Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran 0000-0001-6592-1087 Kambiz Sheykhi Department of General Surgery, School of Medicine, Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran 0000-0002-2702-1747 Salman Soleimani Department of General Surgery, School of Medicine, Lung Transplantation Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran 0009-0005-6356-1678 Khosrow Zabihian Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0009-0007-2504-6485 Hamed Salamatfar Department of Surgery, School of Medicine, Cancer Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-0039-8584 Journal Article 2025 06 21 Background: Primary chest wall tumors originate from different constructions of thoracic wall. This study was conducted with the aim of investigating the clinical outcomes and surgical results of primary malignant tumors of the chest wall Materials and Methods: This study was conducted in a retrograde manner on patients with Primary malignant chest wall tumors treated in the course of 10 years at Masih Daneshvari Hospital. All the mentioned patients were extracted from the cancer registration unit of the hospital and 40 samples were collected. Patient information was extracted based on a pre-designed questionnaire and then analyzed using SPSS statistical software. Results: Out of the 40 patients, 67.6% were men and the average age of the patients was 36.3 years. The complication after surgery were observed in 55% of cases, the most common complications were seroma and wound infection. The one and three overall survival (OS) of patients in the present study was 88% and 61%, respectively. The mean (±SE) survival time (OS) in the R0 to R2 margin increased from 87.6±10.5 and 87.2 ± 20.6 to 15.2 ± 4.5 months, respectively (p-value=0.001). 55% of patients had relapse. The mean (±SE) duration of recurrence (PFS) in the R0 to R2 margin increased from 38.1 ± 8.9 and 31.4 ± 14.1 to 7.9 ± 5.0 months, respectively (p-value=0.02). Conclusion: The one and three overall survival (OS) of studied patients was 88% and 61%, respectively, and half of the patients experienced disease recurrence. The status of the margin was one of the factors affecting the duration of disease-free survival (PFS) and the duration of overall survival (OS).

https://www.caspjs.com/article_725375_6f70faa33f0a4450b4db4a259960b25f.pdf

Babol University of Medical Sciences Caspian Journal of Surgery 3115-9087 1 1 2025 03 01 Evaluation of Urgent Coronary Artery Bypass Grafting (CABG) Survival in Patients With Acute Myocardial Infarction 37 42 724791 10.22088/caspjs.2025.724791 EN Mehdi Tahmasbi Student Research Committee, Babol University of Medical Sciences, Babol, Iran 0009-0009-9723-3241 Kamyar Amin Department of Cardiology, School of Medicine, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran 0000-0002-5111-2059 Hamidreza Vafaee Department of Surgery, School of Medicine, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran 0000-0001-8267-820X Iraj Jafaripour Department of Cardiology, School of Medicine, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran 0000-0002-2702-1747 Hoda Shirafkan Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0002-5682-1153 Journal Article 2025 05 26 Background: Cardiovascular diseases are the leading cause of death in Iran and other countries. Due to the fact that in many centers, it is not possible to perform Urgent Coronary artery bypass grafting (UCABG) and the number of samples performed in other centers is low, so a similar study was not found in Iran. Therefore, the present study was performed to evaluate UCABG survival in patients with acute myocardial infarction. Materials and Methods: In this historical cohort study, all patients with acute myocardial infarction who referred to Ayatollah Rouhani Hospital during 2011-2018 and underwent UCABG were included in the study. This plan was presented in the Ethics Committee of Babol University of Medical Sciences. All patients to be fully followed-up include: 1. Major cardiovascular complications (including cardiac death, major bleeding, and re-MI), 2. Major adverse cardiovascular events, 3. Re-admission rate, and 4. Requirement for angiography and re-angioplasty that the consequences were also evaluable and their history and paraclinical information were included in the file. Results: The mean survival in non-diabetic patients was 55.81 (53.60-58.01) months and in diabetic patients was 56 (53.58-53.46) months which were not statistically significant (p= 0.48). The mean was 56.33 (54.27-39.39) months survival in patients without hypertension and was 55.32 (52.59-55.05) months in patients with hypertension, which was not statistically significant (p=0.40). The mean survival was 55.95 (54.24 - 57.66) months in patients without a history of MI during the first 3 years after surgery and was 54.14 (61.95-46.32) months in patients with a history of MI during the first 3 years after surgery which there did not have a statistically significant difference (p = 0.09). The mean survival was 55.99 (54.09-57.89) months in patients without a history of readmission and was 55.50 (52.01-58.98) months in patients with a history of readmission which were not statistically significant (p=0.33). The mean survival was 55.28 (53.13-57.42) months in men and was 56.95 (54.33-59.56) months in women which was not statistically significant (p = 0.19). According to Cox regression analysis, none of the variables was related to 5-year survival of patients. Conclusion: Based on the results of the present study, the mortality rate in patients undergoing UCABG was 18% over 5 years, which with a median survival of 56 months, had a good feedback in patients with acute myocardial infarction.

https://www.caspjs.com/article_724791_9fe8acc918636af0ec1feb032fe3d63f.pdf

Babol University of Medical Sciences Caspian Journal of Surgery 3115-9087 1 1 2025 03 01 Effects of Loop Diuretics Continuation on AV Fistula Maturation and Clinical Outcomes in Hemodialysis Patient 43 47 724790 10.22088/caspjs.2025.724790 EN Fatemeh Mahmoudlou Student Research Committee, Babol University of Medical Sciences, Babol, Iran 0000-0002-8251-9329 Ali Akbar Moghadamnia Department of Pharmacology and Toxicology, School of Medicine, Babol University of Medical Sciences, Babol, Iran Pharmaceutical Sciences Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0001-7140-1352 Ali Bijani Social Determinants of Health Research Center, Health Research Institute, Babol University of Medical Sciences, Babol, Iran 0000-0003-2233-8726 Iraj Jafaripour Department of Cardiology, School of Medicine, Rouhani Hospital Babol University of Medical Sciences, Babol, Iran 0000-0002-2702-1747 Pouya Tayebi Department of Vascular and Endovascular Surgery, Rouhani Hospital, Babol University of Medical Sciences, Babol, Iran 0000-0002-6923-0221 Journal Article 2025 05 26 Background: Primary chest wall tumors originate from different constructions of thoracic wall. This study was conducted with the aim of investigating the clinical outcomes and surgical results of primary malignant tumors of the chest wall Materials and Methods: This study was conducted in a retrograde manner on patients with Primary malignant chest wall tumors treated in the course of 10 years at Masih Daneshvari Hospital. All the mentioned patients were extracted from the cancer registration unit of the hospital and 40 samples were collected. Patient information was extracted based on a pre-designed questionnaire and then analyzed using SPSS statistical software. Results: Out of the 40 patients, 67.6% were men and the average age of the patients was 36.3 years. The complication after surgery were observed in 55% of cases, the most common complications were seroma and wound infection. The one and three overall survival (OS) of patients in the present study was 88% and 61%, respectively. The mean (±SE) survival time (OS) in the R0 to R2 margin increased from 87.6±10.5 and 87.2±20.6 to 15.2±4.5 months, respectively (P=0.001). 55% of patients had relapse. The mean (±SE) duration of recurrence (PFS) in the R0 to R2 margin increased from 38.1±8.9 and 31.4±14.1 to 7.9±5 months, respectively (P=0.02). Conclusion: The one and three overall survival (OS) of studied patients was 88% and 61%, respectively, and half of the patients experienced disease recurrence. The status of the margin was one of the factors affecting the duration of disease-free survival (PFS) and the duration of overall survival (OS).

https://www.caspjs.com/article_724790_cad8bdb72bad63a95200461c192a5bd5.pdf